ARTICLE | Company News
Emisphere and Eli Lilly follow-on deal
June 13, 2000 7:00 AM UTC
EMIS and LLY announced a follow-on development agreement to their 1997 research and option agreement to develop oral formulations of LLY's Forteo recombinant parathyroid hormone and Humatrope human gr...